Prothena reported 29.2M in Current Liabilities for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 88.22M 7.11M
Adamas Pharmaceuticals ADMS:US 23.84M 2.02M
Agios Pharmaceuticals AGIO:US $ 57.9M 2.75M
Akebia Therapeutics AKBA:US $ 189.2M 23.61M
Alexion Pharmaceuticals ALXN:US $ 1426.2M 198.5M
ALKERMES ALKS:US $ 452.98M 69.54M
Alnylam Pharmaceuticals ALNY:US $ 610.66M 56.01M
Amgen AMGN:US $ 14842M 257M
Biogen BIIB:US $ 4211.6M 864.4M
Biomarin Pharmaceutical BMRN:US $ 514.9M 71.55M
Bluebird Bio BLUE:US $ 266.56M 18.79M
Exelixis EXEL:US $ 269.51M 14.18M
Gw Pharmaceuticals GWPH:US $ 160.25M 0.44M
Intra Cellular Therapies ITCI:US $ 49.9M 0.53M
IONIS PHARMACEUT IONS:US $ 218M 75.82M
Macrogenics MGNX:US $ 68.86M 1.06M
Nektar Therapeutics NKTR:US $ 139.97M 8.95M
Neurocrine Biosciences NBIX:US $ 225.9M 13M
Prothena PRTA:US 29.2M 23.7M
Regeneron Pharmaceuticals REGN:US $ 3714.8M 17.6M
Seattle Genetics SGEN:US $ 698.43M 264.6M
Ultragenyx Pharmaceutical RARE:US $ 135.93M 8.87M
Vertex Pharmaceuticals VRTX:US $ 1914.26M 77.82M
Vital Therapies VTL:US $ 10.59M 3.9M
Xoma XOMA:US $ 6.51M 221K
YTE INCY:US $ 742.71M 82.39M